|
1
|
Rawla P, Sunkara T and Barsouk A: Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors. Prz Gastroenterol. 14:89–103. 2019.PubMed/NCBI
|
|
2
|
De Palma FDE, D'argenio V, Pol J, Kroemer G, Maiuri MC and Salvatore F: The molecular hallmarks of the serrated pathway in colorectal cancer. Cancers (Basel). 11:10172019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Okabe H, Mima K, Saito S, Hayashi H, Imai K, Nitta H, Hashimoto D, Chikamoto A, Ishiko T, Beppu T and Baba H: Epithelial-mesenchymal transition in gastroenterological cancer. J Cancer Metastasis Treat. 1:183–189. 2015. View Article : Google Scholar
|
|
4
|
Loh CY, Chai JY, Tang TF, Wong WF, Sethi G, Shanmugam MK, Chong PP and Looi CY: The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal transition: Signaling, therapeutic implications, and challenges. Cells. 8:11182019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nieto MA, Huang RY, Jackson RA and Thiery JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, Onuchic JN and Levine H: Implications of the hybrid epithelial/mesenchymal phenotype in metastasis. Front Oncol. 5:1552015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Aiello NM and Kang Y: Context-dependent EMT programs in cancer metastasis. J Exp Med. 216:1016–1026. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Saito S, Okabe H, Watanabe M, Ishimoto T, Iwatsuki M, Baba Y, Tanaka Y, Kurashige J, Miyamoto Y and Baba H: CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer. Oncol Rep. 29:1570–1578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tuncay Cagatay S, Cimen I, Savas B and Banerjee S: MTA-1 expression is associated with metastasis and epithelial to mesenchymal transition in colorectal cancer cells. Tumor Biol. 34:1189–1204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Z, Zhao K, Hackert T and Zöller M: CD44/CD44v6 a reliable companion in cancer-initiating cell maintenance and tumor progression. Front Cell Dev Biol. 6:972018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen C, Zhao S, Karnad A and Freeman JW: The biology and role of CD44 in cancer progression: Therapeutic implications. J Hematol Oncol. 11:642018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McAtee CO, Barycki JJ and Simpson MA: Emerging roles for hyaluronidase in cancer metastasis and therapy. Adv Cancer Res. 123:1–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Misra S, Hascall VC, Markwald RR and Ghatak S: Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer. Front Immunol. 6:2012015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Xu D, Wang H, Zhang Y, Chang Y, Zhang J, Wang J, Li C, Liu H, Zhao M, et al: The subcellular distribution and function of MTA1 in cancer differentiation. Oncotarget. 5:5153–5164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lozar T, Gersak K, Cemazar M, Kuhar CG and Jesenko T: The biology and clinical potential of circulating tumor cells. Radiol Oncol. 53:131–147. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Zhou Y and Hu Z: The functions of circulating tumor cells in early diagnosis and surveillance during cancer advancement. J Transl Intern Med. 5:135–138. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Welinder C, Jansson B, Lindell G and Wenner J: Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer. Cancer Lett. 358:43–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lagoudianakis EE, Kataki A, Manouras A, Memos N, Papadima A, Derventzi A, Zografos G, Papadopoulos S, Katergiannakis V and Konstadoulakis MM: Detection of epithelial cells by RT-PCR targeting CEA, CK20, and TEM-8 in colorectal carcinoma patients using OncoQuick density gradient centrifugation system. J Surg Res. 155:183–190. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miller RJ, Banisadr G and Bhattacharyya BJ: CXCR4 signaling in the regulation of stem cell migration and development. J Neuroimmunol. 198:31–38. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Riihimäki M, Hemminki A, Sundquist J and Hemminki K: Patterns of metastasis in colon and rectal cancer. Sci Rep. 6:297652016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liepelt A and Tacke F: Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases. Am J Physiol Gastrointest Liver Physiol. 311:G203–G209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Werb Z and Lu P: The role of Stroma in tumor development. Cancer J. 21:250–253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang L, Liu Q, Lin D and Lai M: CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma. Int J Clin Exp Pathol. 8:14283–14293. 2015.PubMed/NCBI
|
|
24
|
Afify A, Durbin-Johnson B, Virdi A and Jess H: The expression of CD44v6 in colon: From normal to malignant. Ann Diagn Pathol. 20:19–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim H, Yang XL, Rosada C, Hamilton SR and August JT: CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch Biochem Biophys. 310:504–507. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Todaro M, Gaggianesi M, Catalano V, Benfante A, Iovino F, Biffoni M, Apuzzo T, Sperduti I, Volpe S, Cocorullo G, et al: CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell. 14:342–356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao LH, Lin QL, Wei J, Huai YL, Wang KJ and Yan HY: CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression. Int J Clin Exp Pathol. 8:692–701. 2015.PubMed/NCBI
|
|
28
|
Coppola D, Hyacinthe M, Fu L, Cantor AB, Karl R, Marcet J, Cooper DL, Nicosia SV and Cooper HS: CD44V6 expression in human colorectal carcinoma. Hum Pathol. 29:627–635. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zlobec I, Günthert U, Tornillo L, Iezzi G, Baumhoer D, Terracciano L and Lugli A: Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer. Histopathology. 55:564–575. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang JL, Su WY, Lin YW, Xiong H, Chen YX, Xu J and Fang JY: CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis. Oncotarget. 8:12866–12876. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Okabe H, Ishimoto T, Mima K, Nakagawa S, Hayashi H, Kuroki H, Imai K, Nitta H, Saito S, Hashimoto D, et al: CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma. Br J Cancer. 110:958–966. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Minoo P, Zlobec I, Peterson M, Terracciano L and Lugli A: Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int J Oncol. 37:707–718. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Warschkow R, Sulz MC, Marti L, Tarantino I, Schmied BM, Cerny T and Güller U: Better survival in right-sided versus left-sided stage I–III colon cancer patients. BMC Cancer. 16:5542016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aramaki Y, Ogawa K, Toh Y, Ito T, Akimitsu N, Hamamoto H, Sekimizu K, Matsusue K, Kono A, Iguchi H and Takiguchi S: Direct interaction between metastasis-associated protein 1 and endophilin 3. FEBS Lett. 579:3731–3736. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cao G, Chen B and Xiong M: Role of metastasis-associated protein 1 in prognosis of patients with digestive tract cancers: A meta-analysis. PLoS One. 12:e01764312017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Karamagkiolas S, Giotakis I, Kyrodimos E, Giotakis EI, Kataki A, Karagianni F and Lazaris AM: Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients. Am J Otolaryngol. 40:487–493. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen XL, Wu YJ, Lv Z, Zhao HM and Han BJ: Significance of expression of MTA1 and RECK in carcinogenesis of colonic polyps. World Chinese J Dig. 24:4514–4518. 2016. View Article : Google Scholar
|
|
38
|
Bao W, Fu HJ, Xie QS, Wang L, Zhang R, Guo ZY, Zhao J, Meng YL, Ren XL, Wang T, et al: HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells. Gastroenterology. 141:2076–2087.e6. 2011. View Article : Google Scholar : PubMed/NCBI
|
